CDC taps GE to monitor H1N1 activity

TriMed Staff | | Health Imaging | Practice Management
The Centers for Disease Control and Prevention (CDC) has selected GE Healthcare to monitor H1N1 and seasonal influenza activity within the United States.

The company said its Medical Quality Improvement Consortium, powered by GE Clinical Data Services, will collect information every 24 hours from a database of 14 million patient records. The EMRs will take note of flu symptoms, prescriptions and vaccinations administered. Age groups and pregnancy will also be documented.

With EMR data, not only is the company able to accelerate the reporting of aggregate health changes of the U.S. population, they are able to provide clinical data to health professionals, according to GE Healthcare IT Vice President and General Manager Jim Corrigan.

TriMed Staff

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.